Risk of bleeding complications is not increased in patients undergoing rescue versus primary percutaneous coronary intervention for acute myocardial infarction

Journal of Interventional Cardiology

Volumn 18, Issue 5, 2005, Pages 361-365

  Ellis, Keith ^a   Boccalandro, Fernando ^a   Burjonroppa, Sukesh ^a   Muench, Andreas ^a   Giesler, Gregory M ^a   Smalling, Richard W ^a   Sdringola, Stefano ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; TIROFIBAN;

ADULT; ARTICLE; BLEEDING; CARDIOVASCULAR PROCEDURES; CONTROLLED STUDY; CORONARY STENT; DEMOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; ST SEGMENT ELEVATION;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; EVALUATION STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE HEMORRHAGE; RISK FACTORS; TIME FACTORS;

EID: 28444481686     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2005.00071.x     Document Type: Article

References (8)

1. Cannon CP, McCabe C, Gibson CM, et al. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 10A dose-ranging trial. Circulation 1997;95:351-356.
2. Bode C, Smalling RW, Berg G, et al. Randomized comparison of coronary thrombolysis achieved with double bolus reteplase (re-combinant plasminogen activator) and front loaded, accelerated atlteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The Rapid II investigators. Circulation 1996;94:891-898.
3. Antman EM, Gibson CM, de Lemos JA, et al. Combination reperfusion therapy with abciximab and reduced dose reteplase: Results from TIMI 14. The thrombolysis in myocardial infarction (TIMI) 14 investigators. Eur Heart J 2000;21(23):1944-1953.
4. Ellis SG, da Silva ER, Spaulding CM, et al. Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: Insights from the RESCUE I, RESCUE II and other contemporary clinical experiences. Am Heart J 2000;139:1046-1053.
5. Ellis SG, Ribeiro Da Suva E, Heyndrickx G, et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994:90:2280-2284.
6. De Luca G, Suryapranata H, Ottervanger JP, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: Every minute of delay counts. Circulation 2004:109:1223-1225.
7. Miller JM, Smalling RW, Ohman EM, et al. Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO III trial). Am J Cardiol 1999;84:779-784.
8. Cantor WJ, Kaplan AL, Velianou JL, et al. Effectiveness and safety of abciximab after failed thrombolytic therapy. Am J Cardiol 2001;87:439-442.